Consensus on the role of human cytomegalovirus in glioblastoma

Kristine Dziurzynski, Susan M. Chang, Amy B. Heimberger, Robert F. Kalejta, Stuart R Mc Gregor Dallas, Martine Smit, Liliana Soroceanu, Charles S. Cobbs

Research output: Contribution to journalArticle

  • 127 Citations

Abstract

The human cytomegalovirus (HCMV) and glioma symposium was convened on April 17, 2011 in Washington, DC, and was attended by oncologists and virologists involved in studying the relationship between HCMV and gliomas. The purpose of the meeting was to reach a consensus on the role of HCMV in the pathology of gliomas and to clarify directions for future research. First, the group summarized data that describe how HCMV biology overlaps with the key pathways of cancer. Then, on the basis of published data and ongoing research, a consensus was reached that there is sufficient evidence to conclude that HCMV sequences and viral gene expression exist in most, if not all, malignant gliomas, that HCMV could modulate the malignant phenotype in glioblastomas by interacting with key signaling pathways; and that HCMV could serve as a novel target for a variety of therapeutic strategies. In summary, existing evidence supports an oncomodulatory role for HCMV in malignant gliomas, but future studies need to focus on determining the role of HCMV as a glioma-initiating event.

Original languageEnglish (US)
Pages (from-to)246-255
Number of pages10
JournalNeuro-Oncology
Volume14
Issue number3
DOIs
StatePublished - Mar 2012

Fingerprint

Glioblastoma
Cytomegalovirus
Glioma
Viral Genes
Pathology
Phenotype
Gene Expression
Neoplasms

Keywords

  • cancer
  • DNA virus
  • gliomas
  • herpesvirus
  • human cytomegalovirus

ASJC Scopus subject areas

  • Oncology
  • Clinical Neurology
  • Cancer Research

Cite this

Dziurzynski, K., Chang, S. M., Heimberger, A. B., Kalejta, R. F., Dallas, S. R. M. G., Smit, M., ... Cobbs, C. S. (2012). Consensus on the role of human cytomegalovirus in glioblastoma. Neuro-Oncology, 14(3), 246-255. DOI: 10.1093/neuonc/nor227

Consensus on the role of human cytomegalovirus in glioblastoma. / Dziurzynski, Kristine; Chang, Susan M.; Heimberger, Amy B.; Kalejta, Robert F.; Dallas, Stuart R Mc Gregor; Smit, Martine; Soroceanu, Liliana; Cobbs, Charles S.

In: Neuro-Oncology, Vol. 14, No. 3, 03.2012, p. 246-255.

Research output: Contribution to journalArticle

Dziurzynski, K, Chang, SM, Heimberger, AB, Kalejta, RF, Dallas, SRMG, Smit, M, Soroceanu, L & Cobbs, CS 2012, 'Consensus on the role of human cytomegalovirus in glioblastoma' Neuro-Oncology, vol 14, no. 3, pp. 246-255. DOI: 10.1093/neuonc/nor227
Dziurzynski K, Chang SM, Heimberger AB, Kalejta RF, Dallas SRMG, Smit M et al. Consensus on the role of human cytomegalovirus in glioblastoma. Neuro-Oncology. 2012 Mar;14(3):246-255. Available from, DOI: 10.1093/neuonc/nor227

Dziurzynski, Kristine; Chang, Susan M.; Heimberger, Amy B.; Kalejta, Robert F.; Dallas, Stuart R Mc Gregor; Smit, Martine; Soroceanu, Liliana; Cobbs, Charles S. / Consensus on the role of human cytomegalovirus in glioblastoma.

In: Neuro-Oncology, Vol. 14, No. 3, 03.2012, p. 246-255.

Research output: Contribution to journalArticle

@article{b3399cc2e1f44daf89ecfe03abce74ac,
title = "Consensus on the role of human cytomegalovirus in glioblastoma",
abstract = "The human cytomegalovirus (HCMV) and glioma symposium was convened on April 17, 2011 in Washington, DC, and was attended by oncologists and virologists involved in studying the relationship between HCMV and gliomas. The purpose of the meeting was to reach a consensus on the role of HCMV in the pathology of gliomas and to clarify directions for future research. First, the group summarized data that describe how HCMV biology overlaps with the key pathways of cancer. Then, on the basis of published data and ongoing research, a consensus was reached that there is sufficient evidence to conclude that HCMV sequences and viral gene expression exist in most, if not all, malignant gliomas, that HCMV could modulate the malignant phenotype in glioblastomas by interacting with key signaling pathways; and that HCMV could serve as a novel target for a variety of therapeutic strategies. In summary, existing evidence supports an oncomodulatory role for HCMV in malignant gliomas, but future studies need to focus on determining the role of HCMV as a glioma-initiating event.",
keywords = "cancer, DNA virus, gliomas, herpesvirus, human cytomegalovirus",
author = "Kristine Dziurzynski and Chang, {Susan M.} and Heimberger, {Amy B.} and Kalejta, {Robert F.} and Dallas, {Stuart R Mc Gregor} and Martine Smit and Liliana Soroceanu and Cobbs, {Charles S.}",
year = "2012",
month = "3",
doi = "10.1093/neuonc/nor227",
volume = "14",
pages = "246--255",
journal = "Neuro-Oncology",
issn = "1522-8517",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Consensus on the role of human cytomegalovirus in glioblastoma

AU - Dziurzynski,Kristine

AU - Chang,Susan M.

AU - Heimberger,Amy B.

AU - Kalejta,Robert F.

AU - Dallas,Stuart R Mc Gregor

AU - Smit,Martine

AU - Soroceanu,Liliana

AU - Cobbs,Charles S.

PY - 2012/3

Y1 - 2012/3

N2 - The human cytomegalovirus (HCMV) and glioma symposium was convened on April 17, 2011 in Washington, DC, and was attended by oncologists and virologists involved in studying the relationship between HCMV and gliomas. The purpose of the meeting was to reach a consensus on the role of HCMV in the pathology of gliomas and to clarify directions for future research. First, the group summarized data that describe how HCMV biology overlaps with the key pathways of cancer. Then, on the basis of published data and ongoing research, a consensus was reached that there is sufficient evidence to conclude that HCMV sequences and viral gene expression exist in most, if not all, malignant gliomas, that HCMV could modulate the malignant phenotype in glioblastomas by interacting with key signaling pathways; and that HCMV could serve as a novel target for a variety of therapeutic strategies. In summary, existing evidence supports an oncomodulatory role for HCMV in malignant gliomas, but future studies need to focus on determining the role of HCMV as a glioma-initiating event.

AB - The human cytomegalovirus (HCMV) and glioma symposium was convened on April 17, 2011 in Washington, DC, and was attended by oncologists and virologists involved in studying the relationship between HCMV and gliomas. The purpose of the meeting was to reach a consensus on the role of HCMV in the pathology of gliomas and to clarify directions for future research. First, the group summarized data that describe how HCMV biology overlaps with the key pathways of cancer. Then, on the basis of published data and ongoing research, a consensus was reached that there is sufficient evidence to conclude that HCMV sequences and viral gene expression exist in most, if not all, malignant gliomas, that HCMV could modulate the malignant phenotype in glioblastomas by interacting with key signaling pathways; and that HCMV could serve as a novel target for a variety of therapeutic strategies. In summary, existing evidence supports an oncomodulatory role for HCMV in malignant gliomas, but future studies need to focus on determining the role of HCMV as a glioma-initiating event.

KW - cancer

KW - DNA virus

KW - gliomas

KW - herpesvirus

KW - human cytomegalovirus

UR - http://www.scopus.com/inward/record.url?scp=84859557807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859557807&partnerID=8YFLogxK

U2 - 10.1093/neuonc/nor227

DO - 10.1093/neuonc/nor227

M3 - Article

VL - 14

SP - 246

EP - 255

JO - Neuro-Oncology

T2 - Neuro-Oncology

JF - Neuro-Oncology

SN - 1522-8517

IS - 3

ER -